Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Appointed CFO
Quarterly results
Auditor change

Eledon Pharmaceuticals, Inc. (NVUS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Robinson James A. Jr. (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 150,437 options to buy @ $1.55, valued at $233.2k
10/03/2023 4 Kirk Allan (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 150,437 options to buy @ $1.55, valued at $233.2k
10/02/2023 3 Robinson James A. Jr. (Director) has filed a Form 3 on Eledon Pharmaceuticals, Inc.
10/02/2023 3 Kirk Allan (Director) has filed a Form 3 on Eledon Pharmaceuticals, Inc.
05/09/2023 4 BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Bought 1,055,445 shares @ $0
Bought 837,146 shares @ $0
Bought 86,341 shares @ $0
Bought 2,028,645 options to buy @ $0.001, valued at $2k
Bought 1,609,063 options to buy @ $0.001, valued at $1.6k
Bought 165,950 options to buy @ $0.001, valued at $166
Bought 3,084,090 options to buy @ $3, valued at $9.3M
Bought 2,446,209 options to buy @ $3, valued at $7.3M
Bought 252,291 options to buy @ $3, valued at $756.9k
05/02/2023 4 Smith Bryan E. (General Counsel, Corporate Sec) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 179,000 options to buy @ $2.3, valued at $411.7k
05/02/2023 4 Perrin Steven (President) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 317,147 options to buy @ $2.3, valued at $729.4k
05/02/2023 4 Gros David-Alexandre C (CEO) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 383,299 options to buy @ $2.3, valued at $881.6k
05/02/2023 4 Ogier Walter C (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 150,437 options to buy @ $2.3, valued at $346k
05/02/2023 4 Little Paul Sean (CFO) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 198,126 options to buy @ $2.3, valued at $455.7k
05/02/2023 4 Katkin Keith (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 752,185 options to buy @ $2.3, valued at $1.7M
05/02/2023 4 McBride John S. (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 150,437 options to buy @ $2.3, valued at $346k
05/02/2023 4 LYONS GARY A (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 150,437 options to buy @ $2.3, valued at $346k
05/02/2023 4 Lee June (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 150,437 options to buy @ $2.3, valued at $346k
05/02/2023 4 Hillson Jan (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 150,437 options to buy @ $2.3, valued at $346k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Ogier Walter C (Director) has filed a Form 4 on Eledon Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $3.97, valued at $79.4k
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy